'Strong Demand' for SNP Chips Helps Illumina Q4 Revenue Surge 49 Percent | GenomeWeb

Illumina last week said fourth-quarter revenue swelled 43 percent as a loss in the prior-year period swung to a profit in the current quarter, and Chief Financial Officer Christian Henry said it will "probably" make an acquisition that is on the "smaller rather than the larger side."

CEO Jay Flatley said sales of the firm’s whole-genome Infinium HD BeadChips comprised the majority of its revenue, and that its Human610-Quad was its best-selling product for the quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.